Please assess the completion status of the following clinical trial:

Trial Title: Changes in Echogenicity and Muscle Stiffness in Elastography After Botulinum Toxin Injection a Spastic Muscle

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* A first stroke older than nine months (acute phase and subacute stroke).~* Hemiplegia cerebral vascular following this stroke.~* Hemiplegia with an overall motor deficit plegic lower limb muscle testing level less than or equal to 3 and associating a localized spasticity lower plegic member, on the plantar flexors, assessed by the upper Ashworth Scale or equal to 1 with an injection of botulinum toxin indication of the sural triceps.~* written consent.~Exclusion Criteria:~* Old stroke with motor impairment of the lower limb in the chronic stage.~* Concomitant muscle disease (eg myopathy, myositis ...).~* Patients who already received a botulinum toxin injection into the gastrocnemius muscles.~* Subjects with defibrillator

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- patients with hemiplegia after stroke (Type: EXPERIMENTAL): ultrasound echogenicity paraclinical assessment and elastography to patients with hemiplegia following stroke with an indication of injection of botulinum toxin into the triceps sural

Based on this trial design, predict the completion outcome and termination type (if applicable).